News & Trends - MedTech & Diagnostics
Cardinal Health appoints new Managing Director for Australia & New Zealand
MedTech News: Cardinal Health has appointed Jane Crowe as Managing Director of its operations in Australia and New Zealand (ANZ).
Based in Sydney, Jane reports to Roy Noda, President, Asia Pacific, and is a member of Cardinal Health’s Asia Pacific Leadership Team.
In her capacity as Managing Director, Jane will lead all aspects of sales, marketing and stakeholder engagement related to Cardinal Health in ANZ.
She brings 25 years of healthcare industry experience in business transformation, sales, marketing and strategy development to the company.
Jane’s previous role was the Managing Director of Roche Diagnostics ANZ.
Her career spans medical devices, software, pharmaceuticals, communications and service delivery in Australia, New Zealand, and China. In addition to a number of corporate leadership roles, she was also the Executive Director of Community Options Australia, a not-for-profit community-based organisation that provides services to older people, people with disabilities and their families.
“Given her deep experience and leadership ability, I am confident that Cardinal Health ANZ will continue to thrive under her leadership,” said, Roy Noda, President, APAC.
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. It is an US Fortune Top 20 company with operations in 46 countries and approximately 48,000 employees globally.
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More